RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial - Lee, JL; Kim, MK; Park, I (Ann Oncol, 2015)
et al.